(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BOSTONGENE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

BOSTONGENE

ST13

US500000090089889

Classe

42, 44

Pedido

90089889

Registro

6457963

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

23

Atualização mais recente

20/09/2021

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

42, 44

Data de depósito

03/08/2020

Data de registro

17/08/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

17/08/2021

Última transação

20/09/2021

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Supplemental Register

Fundamento do pedido

Intent to use

Primeiro uso

2020-04-00

Primeiro uso no comércio

2020-04-00

Código do desenho

4

Tipo de titular

03

Localização do titular

Waltham, MA

Examinador

WATTS-FITZGERALD, CAITLIN

Unidade examinadora

M20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

B. C. (pessoa física)

Representantes

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.

Classificação técnica

Classes Nice

Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics; medical laboratory services being medical researchin the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of onlinenon-downloadable software for genetic assessment and identification of cancerdiseaseshealth status and metricsgene mutations for scientificmedicaldiagnostictreatmentresearch purposes; providing temporary use of onlinenon-downloadable software used for the sequencing and analyses of genomicproteomictranscriptomic data; providing temporary use of onlinenon-downloadable software used to integrate and create data models; software as a service (SAAS) services featuring software for analyzing and visualizing genomicproteomictranscriptomic dataevaluating health status and diagnosing diseasesdisorderssyndromes; software as a service (SAAS) services featuring software for data managementfor electronic storage of data in the field of clinical trials and electronic health records; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing onlinenon-downloadable computer software for collectinganalyzingreportingtracking data and information in the fields of geneticsgenomicsproteomicstranscriptomicsbiochemistry; providing onlinenon-downloadable software for use in clinical trial data management and for management of electronic health records

Classe 44

Genetic testing for medical purposesspecificallygenomicproteomictranscriptomicmolecular medical testing for cancer and other diagnostic or treatment purposes; Providing medical informationproviding collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; Providing medical informationspecificallyproviding collected and analyzed medical information in the field of genomicsproteomicstranscriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing online computer databases of genomic sequences for medical scientific researchfor medical trackingmatchingsearchingtestingaggregatingresearchingevaluating health statusfor the purpose of diagnosing diseases and gene mutations; providing an online Internet website portal featuring medical informationmedicalgeneticgenomicproteomictranscriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online Internet website portal featuring medical informationmedicalgeneticgenomicproteomictranscriptomic information and data for scientificlaboratorymedical research and development purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

23 publicações encontradas

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

17/08/2021

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

13/07/2021

ALIE

ASSIGNED TO LIE

12/07/2021

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

09/07/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

28/06/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

28/06/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

28/06/2021

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

25/06/2021

IUAA

USE AMENDMENT ACCEPTED

24/06/2021

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

09/06/2021

IUAF

USE AMENDMENT FILED

09/06/2021

EAAU

TEAS AMENDMENT OF USE RECEIVED

08/06/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/03/2021

GNRT

NON-FINAL ACTION E-MAILED

12/03/2021

CNRT

NON-FINAL ACTION WRITTEN

12/03/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/03/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/03/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/03/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

23/11/2020

GNRT

NON-FINAL ACTION E-MAILED

23/11/2020

CNRT

NON-FINAL ACTION WRITTEN

23/11/2020

DOCK

ASSIGNED TO EXAMINER

23/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/09/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BOSTONGENE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.